Hergenrother Lab

Home Research
  • Complex Molecule Synthesis
  • Anticancer Compounds
  • Antibacterial Compounds
News Publications Group Members
  • Prof. Hergenrother
  • Post Docs
  • Graduate Students
  • Undergraduate Students
  • Visiting Scientists
  • Alumni
Group Business
  • Group Jobs
  • Group Meeting Schedule
  • Dissertations
Group Photos Resources & Links Misc.
  • Compound Collection
  • Funding
  • UIUC Affiliations
Group Meeting Schedule (new)

Category: PAC-1

A Phase 1B/2 clinical trial of PAC-1 for patients with metastatic uveal melanoma is now enrolling

Posted on February 11, 2021July 1, 2021 by trubach@illinois.edu

To enroll in the trial, please visit the ClinicalTrials.gov website.

…
Posted in PAC-1
Site Header Image

See story on Pretzel, a pet dog with glioma successfully treated with PAC-1.

Posted on February 20, 2018July 1, 2021 by Lisa Williamson

Clinical trials on companion animals diagnosed with cancer have brought new hope to their owners—and new data for a cutting-edge cancer drug being developed by scientists at Illinois.

By Mary Timmins

On the day we meet Pretzel, the weather is

…
Posted in PAC-1
PAC-1

A Phase 1b clinical trial of PAC-1 for glioblastoma patients has begun

Posted on February 13, 2018July 1, 2021 by Lisa Williamson

A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain. This phase Ib

…
Posted in PAC-1
Site Header Image

The FDA grants Orphan Drug Designation to PAC-1!

Posted on May 24, 2016July 1, 2021 by Lisa Williamson

Human trials of cancer drug PAC-1 continue with new investment.

University of Illinois chemistry professor Paul Hergenrother, right, and veterinary clinical medicine professor Timothy Fan tested an anti-cancer compound in pet dogs that is now being used in human clinical

…
Posted in PAC-1
PAC-1

PAC-1 shows efficacy in dog trial

Posted on October 1, 2015July 1, 2021 by trubach@illinois.edu

Chasing cancer with dogs — Treating canine cancers is helping researchers learn more about human forms of the disease.

Thunder is a middle-aged mutt with a cheery disposition. He is slim, with a black coat and white patches on his

…
Posted in PAC-1

The Phase 1 clinical trial of PAC-1 in human cancer patients has begun!

Posted on February 4, 2015July 1, 2021 by Lisa Williamson

See listing on clinicaltrials.gov, listen to the interview, watch a PBS documentary about comparative oncology including PAC-1, and watch the CBS Chicago report. 

…
Posted in PAC-1
Site Header Image

Vanquish Oncology, Inc. announces multimillion dollar investment to move PAC-1 to human clinical trials for cancer patients.

Posted on July 17, 2013July 2, 2021 by Lisa Williamson

Cancer drug tested in pet dogs is now bound for human trials. University of Illinois chemistry professor Paul Hergenrother, left, and veterinary clinical medicine professor Tim Fan led a study of an anti-cancer compound in pet dogs that is now

…
Posted in PAC-1

Hergenrother Lab

261 Roger Adams Lab

600 S. Mathews Avenue

Urbana, IL, 61802

Email: hergenro@illinois.edu

Department of Chemistry
at the University of Illinois

Go to top